ArticleCancers2024

Rationale for the Initiation, Outcomes, and Characteristics of Chemotherapy Following CDK4/6 Inhibitors in Breast Cancer: A Real-World Cohort Study.

Miroslawa Püsküllüoğlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.